Quote Originally Posted by Wolfwood View Post
210 participants with mild to moderate AD received either 200 mcg of huperzine A, 400 mcg of huperzine A, or placebo twice daily for 16 weeks. While no statistical difference in cognitive scores was noted in patients in the lower dose huperzine A (200mcg) group compared to placebo, the higher dose (400 mcg) of huperzine A led to improved cognition and activities of daily living.

Possibly the dosage then?
thanks for the info about the study.

The thing about the dosage is that Yuschak doesn't mention it and I don't want to just eyeball it. I would also be cautious about taking 'therapeutic' doses, like the ones you mention were used in the study. Just because, I know that galantamine dose for Alzheimer patiens in is several times higher than dose recommended for lucid dreaming.

Have you used Hup-A?